Lixin He

403 total citations
28 papers, 300 citations indexed

About

Lixin He is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Lixin He has authored 28 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Epidemiology and 7 papers in Immunology. Recurrent topics in Lixin He's work include Burn Injury Management and Outcomes (6 papers), Immune Response and Inflammation (6 papers) and Thermal Regulation in Medicine (4 papers). Lixin He is often cited by papers focused on Burn Injury Management and Outcomes (6 papers), Immune Response and Inflammation (6 papers) and Thermal Regulation in Medicine (4 papers). Lixin He collaborates with scholars based in China, United States and Australia. Lixin He's co-authors include Zhi-yong Sheng, Ning Dong, Yan Yu, Yong-ming Yao, Yong-Ming Yao, Lifeng Huang, Lifeng Huang, Ying Ouyang, Xiangfu Chen and Chuyong Lin and has published in prestigious journals such as Journal of Clinical Investigation, Molecular Cell and PLoS ONE.

In The Last Decade

Lixin He

26 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lixin He China 9 107 95 83 38 36 28 300
Changchun Cai China 12 61 0.6× 92 1.0× 193 2.3× 22 0.6× 21 0.6× 17 417
Patrick G. Mullen United States 7 117 1.1× 113 1.2× 177 2.1× 125 3.3× 49 1.4× 10 447
Kejian Qian China 12 80 0.7× 292 3.1× 97 1.2× 96 2.5× 39 1.1× 24 445
Fachun Zhou China 8 50 0.5× 84 0.9× 57 0.7× 39 1.0× 16 0.4× 18 228
Minjie Zhou China 10 54 0.5× 158 1.7× 67 0.8× 24 0.6× 8 0.2× 23 361
Walter L. Biffl United States 6 92 0.9× 65 0.7× 108 1.3× 69 1.8× 64 1.8× 10 329
Cinzia Castagnini Italy 10 18 0.2× 111 1.2× 44 0.5× 37 1.0× 20 0.6× 12 275
Sara C. Sebag United States 12 111 1.0× 169 1.8× 75 0.9× 109 2.9× 13 0.4× 15 453
Ramona Sturm Germany 12 75 0.7× 79 0.8× 70 0.8× 51 1.3× 31 0.9× 34 289
Youcef Bouazza France 7 83 0.8× 79 0.8× 281 3.4× 24 0.6× 49 1.4× 10 413

Countries citing papers authored by Lixin He

Since Specialization
Citations

This map shows the geographic impact of Lixin He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixin He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixin He more than expected).

Fields of papers citing papers by Lixin He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lixin He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixin He. The network helps show where Lixin He may publish in the future.

Co-authorship network of co-authors of Lixin He

This figure shows the co-authorship network connecting the top 25 collaborators of Lixin He. A scholar is included among the top collaborators of Lixin He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lixin He. Lixin He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Shu‐Mei, Dongni Shi, Shuqin Dai, et al.. (2025). RNF31 induces paclitaxel resistance by sustaining ALYREF cytoplasmic–nuclear shuttling in human triple‐negative breast cancer. Clinical and Translational Medicine. 15(2). e70203–e70203. 4 indexed citations
2.
He, Lixin, Wenjuan Xiong, Ying Zhang, et al.. (2025). Development of an efficient chimeric trifunctional xylanase/glucanase/feruloyl esterase and its application in the bioconversion of corn stover into fermentable sugars. International Journal of Biological Macromolecules. 307(Pt 4). 142236–142236. 2 indexed citations
3.
Wang, Min, Lixin He, Baolin Zhang, et al.. (2024). Osteoblast‐Derived ECM1 Promotes Anti‐Androgen Resistance in Bone Metastatic Prostate Cancer. Advanced Science. 12(2). e2407662–e2407662. 3 indexed citations
4.
Yang, Muwen, Weijing Zhang, Dongni Shi, et al.. (2024). Targeting the SPC25/RIOK1/MYH9 Axis to Overcome Tumor Stemness and Platinum Resistance in Epithelial Ovarian Cancer. Advanced Science. 11(47). e2406688–e2406688. 3 indexed citations
5.
Yang, Muwen, Lingzhi Kong, Shu‐Mei Huang, et al.. (2023). Inhibition of DPAGT1 suppresses HER2 shedding and trastuzumab resistance in human breast cancer. Journal of Clinical Investigation. 133(14). 14 indexed citations
6.
Li, Yue, Boyu Chen, Xingyu Jiang, et al.. (2023). A Wnt-induced lncRNA-DGCR5 splicing switch drives tumor-promoting inflammation in esophageal squamous cell carcinoma. Cell Reports. 42(6). 112542–112542. 12 indexed citations
7.
He, Lixin, Shu‐Mei Huang, Pian Liu, et al.. (2023). Lysosomal cyst(e)ine storage potentiates tolerance to oxidative stress in cancer cells. Molecular Cell. 83(19). 3502–3519.e11. 29 indexed citations
8.
Liu, Qinghua, Xinjian Huang, Qingyuan Li, et al.. (2020). Rhophilin‐associated tail protein 1 promotes migration and metastasis in triple negative breast cancer via activation of RhoA. The FASEB Journal. 34(8). 9959–9971. 6 indexed citations
9.
He, Lixin, et al.. (2020). Synaptic development of layer V pyramidal neurons in the prenatal human prefrontal neocortex: a Neurolucida-aided Golgi study. Neural Regeneration Research. 15(8). 1490–1490. 6 indexed citations
10.
Li, Gang, Meng Wang, Liangliang Ren, et al.. (2019). Regulator of G protein signaling 20 promotes proliferation and migration in bladder cancer via NF-κB signaling. Biomedicine & Pharmacotherapy. 117. 109112–109112. 14 indexed citations
11.
Huang, Lifeng, Yong-ming Yao, Ning Dong, et al.. (2016). [Prognostic significance of plasma gelsolin in severe burn patients with sepsis].. PubMed. 32(2). 77–81. 3 indexed citations
12.
Yang, Lang, et al.. (2014). [Clinical study on continuous plasma filtration absorption treatment for burn sepsis].. PubMed. 30(4). 310–4. 3 indexed citations
13.
Huang, Lifeng, Yong-ming Yao, Jinfeng Li, et al.. (2011). Reduction of Plasma Gelsolin Levels Correlates with Development of Multiple Organ Dysfunction Syndrome and Fatal Outcome in Burn Patients. PLoS ONE. 6(11). e25748–e25748. 26 indexed citations
14.
Dong, Ning, et al.. (2010). [Influence of CD14 gene polymorphism on the expression of high mobility group box-1 protein in patients with severe burn].. PubMed. 26(2). 109–12. 4 indexed citations
15.
Huang, Lifeng, Yong-ming Yao, Ning Dong, et al.. (2010). Association of high mobility group box-1 protein levels with sepsis and outcome of severely burned patients. Cytokine. 53(1). 29–34. 35 indexed citations
16.
Huang, Lifeng, Yong-Ming Yao, Ning Dong, et al.. (2010). Association between regulatory T cell activity and sepsis and outcome of severely burned patients: a prospective, observational study. Critical Care. 14(1). R3–R3. 75 indexed citations
17.
Zhu, Jingmin, et al.. (2008). [Repair of occipital and nuchal wounds with inferior trapezius myocutaneous flaps in patients after high voltage electrical burn].. PubMed. 24(3). 210–2. 1 indexed citations
18.
He, Lixin, et al.. (2005). [Burn shock fluid resuscitation regime revised by invasive hemodynamic monitoring].. PubMed. 85(23). 1585–7. 1 indexed citations
19.
Li, Feng, et al.. (2004). [Effects of the escharectomy during burn shock stage on expression of glucose translator-4 mRNA in skeletal muscle and adipose tissue].. PubMed. 42(7). 396–9. 2 indexed citations
20.
Gao, Wei, et al.. (1997). Anisodamine restores bowel circulation in burn shock. Burns. 23(2). 142–146. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026